Preclinical Outsourcing

Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing

Charles River Launches Alternative Methods Advancement Project

Aims to develop alternatives to reduce animal testing and to drive a new standard for drug discovery and development.

04.16.24

Medincell, Abbvie Enter Development and Commercialization Pact

Medincell will provide formulation activities and preclinical studies, including supportive CMC work to advance candidates into trials.

04.16.24

cGMP Manufacture | Drug Development | Drug Discovery | Preclinical Outsourcing | Process Development

Anitbody Discovery and Engineering

From DNA to Drug Product

03.13.24

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Preclinical Outsourcing

Charles River, Wheeler Bio Partner to Accelerate Discovery to IND Submission

Agreement combines Charles River’s experience in antibody discovery services, safety, and analytics with Wheeler’s Portable CMC platform.

02.21.24

Breaking News | Preclinical Outsourcing | Promotions & Moves | R&D

StageBio Names David Bruning as CEO

Bruning brings over 25 years of leadership experience within product-based and preclinical testing services companies.

02.12.24

Breaking News | Clinical Trials | CRO News | Laboratory Testing | Preclinical Outsourcing

iuvo BioScience Acquires Promedica International

To support customers from the early preclinical and lab stages through all phases of clinical development.

01.18.24

Breaking News | Collaborations & Alliances | Drug Discovery | Preclinical Outsourcing

Charles River, CELLphenomics Partner on 3D In Vitro Services

CELLphenomics’ PD3D tumor model platform will expand Charles River’s portfolio of 3D in vitro testing services.

12.12.23

APIs | Breaking News | Drug Development | Industry News | Preclinical Outsourcing

Evonik Unveils EUDRACAP Oral Capsule for Preclinical Trials

Enables pharma companies to optimize drug development by reducing cost, time, and variables during preclinical trials.

10.18.23

Breaking News | Drug Development | Industry News | Preclinical Outsourcing

Altasciences Selected by Virpax to Support Flu Drug

The project has completed safety assessment utilizing intranasal administration at Altasciences’ nonclinical site in Columbia, MO.

09.21.23

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Preclinical Outsourcing

Biocytogen, Myricx Enter ADC Option and License Agreement

Myricx will provide linker and payload and Biocytogen will use its RenMice-derived fully human antibodies to make ADCs.

09.08.23

Breaking News | cGMP Manufacture | Industry News | Preclinical Outsourcing

Charles River, Fondazione Telethon Partner on Plasmid Manufacturing

Charles River to manufacture HQ plasmid DNA for Fondazione Telethon’s lentivirus production.

08.24.23

Breaking News | Facilities | Industry News | Preclinical Outsourcing

Biocytogen Opens New Facility in Massachusetts

New location will focus on preclinical contract research services and the distribution of specialized animal model products.

08.23.23

Breaking News | Facilities | Industry News | Preclinical Outsourcing

Charles River Expands Access to AAALAC-Accredited Space

New CRADL spaces in Seattle and Philadelphia will provide flexible vivarium space for biopharmaceutical industry.

08.01.23

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Preclinical Outsourcing

ABL Enters Seven-year Multimillion Dollar Contract with NIH

Will support product development processes, documentation and production of customized recombinant proteins and monoclonal antibodies.

07.20.23

Breaking News | CRO News | Drug Discovery | Facilities | Preclinical Outsourcing

Texcell Unveils State-of-the-Art Viral Clearance Testing Facility

Will support biosafety studies for monoclonal antibodies, gene therapies, and medical devices coming to the market.

06.15.23

Breaking News | CRO News | Industry News | Laboratory Testing | Preclinical Outsourcing

AmplifyBio Expands Cell Therapy Characterization, Fills Gap in Preclinical Development

Adds technology platforms and capabilities in single-cell analysis and product assessment in the context of a tumor microenvironment.

03.16.23

Charles River Launches pHelper Offering for AAV-based Gene Therapies

Designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing.

03.09.23

Center for Breakthrough Medicines Offers Preclinical Package for IND-enabling Activities

Aims to enable the generation of high quality material and data in under five months to move rapidly towards IND approval and GMP clinical manufacturing.

03.07.23

Breaking News | Preclinical Outsourcing